News | EP Mapping and Imaging Systems | October 06, 2015

AcQMap System Shows Improved 3-D Mapping Over CT During AFib Ablation

Technology demonstrates higher resolution, faster mapping times during treatment of cardiac arrhythmias

Acutus Medical, AcQMap High Resolution Imaging and Mapping System, improvement over sCT

Image courtesy of Acutus Medical

October 6, 2015 — Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High Resolution Imaging and Mapping System more rapidly and clearly maps atrial fibrillation (AF) than segmented computed tomography (sCT) mapping, the current standard for most AF ablation procedures.  The initial study findings were presented during an oral presentation at the 10th annual Heart Rhythm Congress held in Birmingham, United Kingdom, Oct. 4-7, 2015.

The abstract titled, “Novel Global Ultrasound Imaging And Continuous Dipole Density Mapping: Initial Findings In AF Patients” was presented by Patrick Heck, M.D., Ph.D, Papworth Hospital, Cambridge, UK. The study evaluated the difference in mapping clarity and detection time between the AcQMap System and sCT in six patients diagnosed with complex arrhythmias. The findings concluded that the AcQMap System reconstructed an image of the atrium at 4.1 times higher resolution than that of sCT. The System also detected the arrhythmia more quickly than sCT (4:07 minutes versus 6:39 minutes, respectively).

“These data underscore the potential advantage the AcQMap System can provide to electrophysiologists (EPs) during AF procedures compared to current standards of mapping technology,” said Heck.  “The image quality of the AcQMap System is unparalleled and allows EPs to see areas of the heart chamber we’ve never been able to visualize before. This is an impressive leap forward, truly opening the possibility to map AF with more precision to identify areas of interest as potential ablation targets.”

The AcQMap System can generate real-time ultrasound images of the heart chamber with quality equivalent to a CT or magnetic resonance image (MRI) in a matter of minutes. The system is the first and only to detect and display both the standard voltage-based maps as well as the higher resolution source charge (dipole density) maps through a proprietary algorithm. The result of combining highly accurate imaging with higher resolution mapping capabilities enables EPs to identify and locate the responsible charge for the arrhythmia, precisely target treatment areas and minimize unnecessary heart ablations.

For more information: www.acutusmedical.com

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin
News | Antiplatelet and Anticoagulation Therapies| August 28, 2017
August 28, 2017 — Bristol-Myers Squibb Company and Pfizer Inc.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Overlay Init